Related Experiment Video
Updated: May 9, 2026
07:51
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
Familial idiopathic pulmonary fibrosis
K Wytrychowski1, A Hans-Wytrychowska, B Nowakowska
1Department of Internal Diseases, Gerontology and Allergology, Wroclaw Medical University, 4 Pasteura St, 50-369, Wroclaw, Poland, anhw@op.pl.
Advances in Experimental Medicine and Biology
|July 10, 2013
Summary
Familial idiopathic pulmonary fibrosis (IPF) is a hereditary lung disease. This study investigated human leukocyte antigen (HLA) alleles in two families with IPF but found no link to major histocompatibility complex (MHC) polymorphisms.
Area of Science:
- Pulmonology
- Genetics
- Immunology
Background:
- Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal lung disease with unknown causes.
- Familial IPF, affecting multiple family members, suggests a hereditary component, often autosomal dominant with variable penetrance.
- Understanding the genetic factors in familial IPF is crucial for diagnosis and potential treatments.
Observation:
- Two families (A and B) with histologically confirmed IPF were studied from 2002 onwards.
- Family A included affected siblings and a niece; Family B included an affected father and his children.
- Human leukocyte antigen (HLA) alleles, including Class I and Class II loci, were examined in affected individuals and healthy relatives.
Findings:
- Histological confirmation of IPF was established for all affected individuals in both families.
- Analysis of HLA alleles in both families did not reveal a correlation between major histocompatibility complex (MHC) polymorphisms and IPF incidence.
- No definitive genetic link was established between MHC variations and the observed familial pulmonary fibrosis.
Implications:
- The study highlights the complexity of familial IPF genetics beyond MHC associations.
- Further research is needed to identify specific genetic markers or environmental factors contributing to hereditary IPF.
- Identifying genetic predispositions could lead to earlier diagnosis and targeted therapeutic strategies for familial pulmonary fibrosis.
Related Concept Videos
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:30Pulmonary Hypertension: Classification and Pathogenesis
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...